Unlock instant, AI-driven research and patent intelligence for your innovation.

Ch3 domain epitope tags

A technology of domains and structural loops, applied in peptides, immunoglobulins, hybrid immunoglobulins, etc.

Pending Publication Date: 2021-03-30
IMMUNOME INC
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the development of each anti-idiotypic mAb is time and resource intensive because each antibody-based biologic requires its own detection antibody

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ch3 domain epitope tags
  • Ch3 domain epitope tags
  • Ch3 domain epitope tags

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1. Ig-fold protein derived epitope tags. Briefly, sequence modifications within the AB, CD, and EF loops are based on the substitution of AB, CD, or EF loop wild-type sequences with sequences derived from the corresponding domains of other structurally related Ig-fold proteins. This approach resulted in the identification of unique epitopes for incorporation into the human CH3 domain. Sequence modifications of the AB loop were generated in the context of the G1m1 and nG1m1 allotypes (DEL and (vs) EEM, respectively).

[0054] Identification of sequences corresponding to the AB, EF and CD loops by performing a multiple sequence alignment of the primary amino acid sequences of various Ig-fold proteins with the CH2 and CH3 domain sequences of the human IgG1 Fc region derived from the crystal structure associated with PDB 4WI2 Candidate Ig-fold CH3 loop sequences, summarized in Figures 2A-2C middle. up to April 11, 2018 , the alignment contains eight Ig-fold p...

Embodiment 2

[0065]Example 2. Sterically favorable amino acid substitutions in the AB and EF loops. Using the molecular visualization system software PyMOL, the positions of the loops were modeled using the human IgG1 Fc region derived from the PDB 4WI2 or 4NOU crystal structures and the solvent-exposed amino acid side chains within the AB and EF loops were identified. Modeling of amino acid substitutions using PyMOL's mutagenesis features allowed analysis of the steric effects of various amino acid substitutions for residues exposed on the inner surface of the AB and EF loops. Substitutions that did not cause steric hindrance were considered for further analysis. Tables 4 and 5 contain candidate AB and EF epitope amino acid sequences, respectively, formed by recognition of sterically favorable substitutions in the surface exposed loops of the AB and EF loops.

[0066] Table 4

[0067]

[0068] table 5

[0069]

[0070] * Amino acids with side chains pointing towards the interio...

Embodiment 3

[0071] Example 3. CD loop sequence modification. Using the molecular visualization system software PyMOL, the position of the loop was modeled using the human IgG1 Fc region derived from the crystal structure of PDB 4WI2 or 4NOU, and the solvent-exposed amino acid side chains within the CD loop sequence were identified. Using this method, the steric effects of sequence modifications in the context of the CD loop can be analyzed. Amino acid substitutions were selected based on similarity in charge, isoelectric point (pl), and polarity at each amino acid position. Another general consideration in designing CD epitopes is to avoid hydrophobic blocks on the outside of the antibody. Table 6 contains a list of candidate CD epitope tag sequences selected by using the aforementioned strategy.

[0072] Table 6

[0073]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to the incorporation of one, or more, heterologous antibody epitopes into the AB, EF, or CD structural loops of the constant heavy domain 3 (''CH3 domain'') of an engineered antibody or Fc-linked therapeutic agent. The heterologous epitopes serve as "epitope tags" that are specifically detectable by epitope tag-specific detector antibodies, irrespective of the tagged agent'starget specificity. Therefore, the epitope tags are useful for the rapid detection of any tagged antibody or Fc- linked agent in biological samples, including samples, which also contain endogenous antibodies.

Description

technical field [0001] The field of the invention relates to the use of heterologous antibody epitopes to facilitate the detection of antibody-based biologicals in biological samples. Background technique [0002] Antibody-based biologics, such as therapeutic antibodies and Fc fusion proteins, are often developed on the human immunoglobulin G (IgG) scaffold to minimize undesired receptor-mediated immune responses to biologics following their administration . However, because humans naturally produce IgG that circulates systemically, the IgG scaffold environment of administered biologicals makes it difficult to detect biologicals within patient samples due to the background presence of endogenous human IgG. Having the ability to detect biologics in patient samples is important because assays for tracking serum levels and pharmacokinetic ("PK") behavior of biologics are routinely available to optimize dosing of biologics. [0003] Practitioners typically rely on anti-idiotyp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/395C07K16/00C07K16/46C07K19/00C12N15/00C12N15/09
CPCC07K16/00C07K16/46C07K2317/526C07K2317/92C07K2317/94C07K2318/10C07K2319/40C07K16/4241C07K2317/24
Inventor M·K·罗宾逊M·J·莫林
Owner IMMUNOME INC